Aeglea BioTherapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Option
QUINN ANTHONY G. director, officer: President & ..
 Director Stock Option (right to buy) 3,307 $5.46 $18,056
Option
QUINN ANTHONY G. director, officer: President & ..
 Common Stock 3,307 $5.46 $18,056
Sale
NOVARTIS BIOVENTURES LTD 10 percent owner
 Common Stock 19,550 $10.06 $196,673
Sale
NOVARTIS BIOVENTURES LTD 10 percent owner
 Common Stock 22,725 $10.13 $230,204
Sale
NOVARTIS BIOVENTURES LTD 10 percent owner
 Common Stock 51,230 $10.11 $517,935
Sale
NOVARTIS BIOVENTURES LTD 10 percent owner
 Common Stock 26,557 $10.03 $266,367
Sale
NOVARTIS BIOVENTURES LTD 10 percent owner
 Common Stock 15,548 $10.11 $157,190
Option
QUINN ANTHONY G. director, officer: President & ..
 Director Stock Option (right to buy) 15,211 $5.46 $83,052
Option
QUINN ANTHONY G. director, officer: President & ..
 Common Stock 15,211 $5.46 $83,052
Purchase
QUINN ANTHONY G. director, officer: President & ..
 Common Stock 2,000 $6.02 $12,040
Purchase
QUINN ANTHONY G. director, officer: President & ..
 Common Stock 600 $5.07 $3,039
Purchase
QUINN ANTHONY G. director, officer: President & ..
 Common Stock 2,800 $4.99 $13,966
Purchase
QUINN ANTHONY G. director, officer: President & ..
 Common Stock 4,888 $4.93 $24,073
Purchase
QUINN ANTHONY G. director, officer: President & ..
 Common Stock 5,065 $4.93 $24,976
Purchase
YORK CHARLES N II officer: Chief Financial Office..
 Common Stock 10,241 $4.76 $48,696
Purchase
QUINN ANTHONY G. director, officer: President & ..
 Common Stock 7,956 $4.98 $39,621
Purchase
YORK CHARLES N II officer: Chief Financial Office..
 Common Stock 3,259 $4.97 $16,197
Purchase
QUINN ANTHONY G. director, officer: President & ..
 Common Stock 4,100 $4.53 $18,577
Purchase
YORK CHARLES N II officer: Chief Financial Office..
 Common Stock 6,500 $4.59 $29,855
Purchase
YORK CHARLES N II officer: Chief Financial Office..
 Common Stock 1,959 $2.52 $4,929
Purchase
ORBIMED ADVISORS LLC 10 percent owner
 Common Stock 7,000 $5.36 $37,520
Purchase
ORBIMED ADVISORS LLC 10 percent owner
 Common Stock 71,800 $5.19 $372,642
Purchase
ORBIMED ADVISORS LLC 10 percent owner
 Common Stock 30,500 $5.04 $153,720
Purchase
YORK CHARLES N II officer: Chief Financial Office..
 Common Stock 2,000 $4.28 $8,568
Purchase
YORK CHARLES N II officer: Chief Financial Office..
 Common Stock 2,000 $4.28 $8,568
Purchase
COX RUSSELL J. director
 Common Stock 7,000 $10 $70,000
Purchase
QUINN ANTHONY
Common Stock 10,000 $10 $100,000
Purchase
LILLY ELI & CO 10 percent owner
 Common Stock 500,000 $10 $5,000,000
Purchase
NOVARTIS BIOVENTURES LTD 10 percent owner
 Common Stock 300,000 $10 $3,000,000

Showing 50 to 79 of 79 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: